Pyrimidine and triazine sulfonamide derivates as B1 bradykinin receptor (B1R) inhibitors for treating pain

Details for Australian Patent Application No. 2009306723 (hide)

Owner Grunenthal GmbH

Inventors Schunk, Stefan; Reich, Melanie; Hennig, Kamila; Engels, Michael; Germann, Tieno; Jostock, Ruth; Hees, Sabine

Agent Spruson & Ferguson

Pub. Number AU-A-2009306723

PCT Pub. Number WO2010/046109

Priority 08018514.3 23.10.08 EP

Filing date 22 October 2009

Wipo publication date 29 April 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/046109 Priority application(s): WO2010/046109

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009306733-Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine

2009306722-Substituted 4,5,6,7-tetrahydrothienopyridines as KCNQ2/3 modulators for treating pain, epilepsy and urinary incontinence